Michael Ferns

Dr. Michael Ferns

orcid

Research Focus & Metrics

Academic Career Length

38Years (1989-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 1993 in Neuron
Verified
Journal Article
Closed access
MFMichael Ferns
Michael Ferns
JCJames T. Campanelli
James T. Campanelli
WHWerner Hoch
Werner Hoch
RSRichard H. Scheller
Richard H. Scheller
ZHZach Hall
Zach Hall

1 June 1992 in Neuron
Verified
Journal Article
Closed access
MFMichael Ferns
Michael Ferns
WHWerner Hoch
Werner Hoch
JCJames T. Campanelli
James T. Campanelli
FRFabio Rupp
Fabio Rupp
ZHZach W. Hall
Zach W. Hall
RSRichard H. Scheller
Richard H. Scheller

1 September 1993 in Neuron
Verified
Journal Article
Closed access
WHWerner Hoch
Werner Hoch
MFMichael Ferns
Michael Ferns
JCJames T. Campanelli
James T. Campanelli
ZHZach W. Hall
Zach W. Hall
RSRichard H. Scheller
Richard H. Scheller

1 March 1996 in Journal of Cell Biology
Verified
Journal Article
Open access
MFMichael Ferns
Michael Ferns
MDM Deiner
M Deiner
ZHZ Hall
Z Hall
Agrin is thought to be the nerve-derived factor that initiates acetylcholine receptor (AChR) clustering at the developing neuromuscularjunction. We have investigated the signaling pathway in mouse C2 myotubes and report that agrin induces a rapid but transient tyrosine phosphorylation of the AChR beta subunit. As the beta-subunit tyrosine phosphorylation occurs before the formation of AChR clusters, it may serve as a precursor step in the clustering mechanism. Consistent with this, we observed that tyrosine phosphorylation of the beta subunit correlated precisely with the presence or absence of clustering under several experimental conditions. Moreover, two tyrosine kinase inhibitors, herbimycin and staurosporine, that blocked beta-subunit phosphorylation also blocked agrin-induced clustering. Surprisingly, the inhibitors also dispersed preformed AChR clusters, suggesting that the tyrosine phosphorylation of other proteins may be required for the maintenance of receptor clusters. These findings indicate that in mammalian muscle, agrin-induced AChR clustering occurs through a mechanism that requires tyrosine phosphorylation and may involve tyrosine phosphorylation of the AChR itself.

26 March 2001 in Journal of Cell Biology
Verified
Journal Article
Open access
PDF file
LBLúcia S. Borges
Lúcia S. Borges
MFMichael Ferns
Michael Ferns
At the developing neuromuscular junction, a motoneuron-derived factor called agrin signals through the muscle-specific kinase receptor to induce postsynaptic aggregation of the acetylcholine receptor (AChR). The agrin signaling pathway involves tyrosine phosphorylation of the AChR β subunit, and we have tested its role in receptor localization by expressing tagged, tyrosine-minus forms of the β subunit in mouse Sol8 myotubes. We find that agrin-induced phosphorylation of the β subunit occurs only on cell surface AChR, and that AChR-containing tyrosine-minus β subunit is targeted normally to the plasma membrane. Surface AChR that is tyrosine phosphorylated is less detergent extractable than nonphosphorylated AChR, indicating that it is preferentially linked to the cytoskeleton. Consistent with this, we find that agrin treatment reduces the detergent extractability of AChR that contains tagged wild-type β subunit but not tyrosine-minus β subunit. In addition, agrin-induced clustering of AChR containing tyrosine-minus β subunit is reduced in comparison to wild-type receptor. Thus, we find that agrin-induced phosphorylation of AChR β subunit regulates cytoskeletal anchoring and contributes to the clustering of the AChR, and this is likely to play an important role in the postsynaptic localization of the receptor at the developing synapse.

1 February 2003 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
MMMartijn Moransard
Martijn Moransard
LBLucia S. Borges
Lucia S. Borges
RWRaffaella Willmann
Raffaella Willmann
PMP. Angelo Marangi
P. Angelo Marangi
HBHans Rudolf Brenner
Hans Rudolf Brenner
CFChristian Fuhrer
Christian Fuhrer
Smac/DIABLO is a mitochondrial protein that is proteolytically processed and released during apoptosis along with cytochrome c and other proapoptotic factors. Once in the cytosol, Smac protein binds to inhibitors ofapoptosis (IAP) proteins and disrupts the ability of the IAPs to inhibit caspases 3, 7, and 9. The requirement for mitochondrial processing and release has complicated efforts to delineate the effect of Smac overexpression and IAP inhibition on cell death processes. In this report, we document a novel expression system using ubiquitin fusions to express mature, biologically active Smac in the cytosol of transfected cells. Processing of the ubiquitin-Smac fusions is rapid and complete and generates mature Smac protein initiating correctly with the Ala-Val-Pro-Ile tetrapeptide sequence that is required for proper function. The biological activity of this exogenous protein was demonstrated by its interaction with X-linked IAP, one of the most potent of the IAPs. The presence of mature Smac was not sufficient to trigger apoptosis of healthy cells. However, cells with excess Smac protein were greatly sensitized to apoptotic triggers such as etoposide exposure. Cancer cells typically display deregulated apoptotic pathways, including Bcl2 overexpression, thereby suppressing the release of cytochrome c and Smac. The ability to circumvent the requirement for mitochondrial processing and release is critical to developing Smac as a possible gene therapy payload in cancer chemosensitization.